|Articles|October 1, 2002

New Directions for Type 2 Diabetes Mellitus Management
Volume 8
Issue 16 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

almost 24 years ago

Article

New Directions for Type 2 Diabetes Mellitus Management

almost 24 years ago

Article

Long-term Consequences of Type 2 Diabetes Mellitus: Economic Impact on Society and Managed Care

almost 24 years ago

Article

Understanding Type 2 Diabetes Mellitus and Associated Cardiovascular Disease: Linked by Insulin Resistance

almost 24 years ago

Article

Current Treatment Approaches of Type 2 Diabetes Mellitus: Successes and Shortcomings

almost 24 years ago

Article

Effects of Thiazolidinediones for Early Treatment of Type 2 Diabetes Mellitus

almost 24 years ago

Article

Thiazolidinediones in the Treatment of Managed Care Patients with Type 2 Diabetes

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Participating Faculty

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

AI Chatbots Score Below 28% on Colorectal Cancer Questions

Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Biologics Appear Renal-Safe in Psoriasis, IL-17 Agents Show Kidney Promise

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Participating Faculty

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

AI Chatbots Score Below 28% on Colorectal Cancer Questions

Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Biologics Appear Renal-Safe in Psoriasis, IL-17 Agents Show Kidney Promise